In relapsed or refractory diffuse large B-cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine
Caimi PF, et al. eJHaem. Nov 2023
Email this document.
Enter your email address below to send this document.